Contracts › HT942525CE032
HT942525CE032: Sbir Phase Ii Proposal Titled Innovative and Adaptive Drug Delivery System for Enhanced Neuroprotection and Repair in Traumatic Brain Injuries From Penetrating Trauma or Open Skull Fractures in Low Resource Environments
Awarded to Altrazeal Life Sciences Inc by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
04 January 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942525CE032 |
|---|---|
| Awardee | Altrazeal Life Sciences Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | TX |
| Offers received | 3 |
| Period of performance | 05 September 2025 to 04 January 2028 |
| Potential end | 04 January 2028 |
| Estimated recompete solicitation | ~Q3 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record